BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 17210474)

  • 1. The regulation of the inflammatory response through nuclear factor-kappab pathway by angiotensin IV extends the role of the renin angiotensin system in cardiovascular diseases.
    Ruiz-Ortega M; Esteban V; Egido J
    Trends Cardiovasc Med; 2007 Jan; 17(1):19-25. PubMed ID: 17210474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin IV activates the nuclear transcription factor-kappaB and related proinflammatory genes in vascular smooth muscle cells.
    Esteban V; Ruperez M; Sánchez-López E; Rodríguez-Vita J; Lorenzo O; Demaegdt H; Vanderheyden P; Egido J; Ruiz-Ortega M
    Circ Res; 2005 May; 96(9):965-73. PubMed ID: 15831814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of diabetes-induced retinal inflammation by blocking the angiotensin II type 1 receptor or its downstream nuclear factor-kappaB pathway.
    Nagai N; Izumi-Nagai K; Oike Y; Koto T; Satofuka S; Ozawa Y; Yamashiro K; Inoue M; Tsubota K; Umezawa K; Ishida S
    Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4342-50. PubMed ID: 17724226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin II signal transduction through the AT1 receptor: novel insights into mechanisms and pathophysiology.
    Higuchi S; Ohtsu H; Suzuki H; Shirai H; Frank GD; Eguchi S
    Clin Sci (Lond); 2007 Apr; 112(8):417-28. PubMed ID: 17346243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of dietary salt on intrarenal angiotensin system, NAD(P)H oxidase, COX-2, MCP-1 and PAI-1 expressions and NF-kappaB activity in salt-sensitive and -resistant rat kidneys.
    Chandramohan G; Bai Y; Norris K; Rodriguez-Iturbe B; Vaziri ND
    Am J Nephrol; 2008; 28(1):158-67. PubMed ID: 17951998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of adhesion molecule expression in human endothelial and smooth muscle cells by omega-3 fatty acids and conjugated linoleic acids: involvement of the transcription factor NF-kappaB?
    Goua M; Mulgrew S; Frank J; Rees D; Sneddon AA; Wahle KW
    Prostaglandins Leukot Essent Fatty Acids; 2008 Jan; 78(1):33-43. PubMed ID: 18036803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the renin-angiotensin system in vascular inflammation.
    Marchesi C; Paradis P; Schiffrin EL
    Trends Pharmacol Sci; 2008 Jul; 29(7):367-74. PubMed ID: 18579222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin II as a pro-inflammatory mediator.
    Phillips MI; Kagiyama S
    Curr Opin Investig Drugs; 2002 Apr; 3(4):569-77. PubMed ID: 12090726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular inflammation in hypertension and diabetes: molecular mechanisms and therapeutic interventions.
    Savoia C; Schiffrin EL
    Clin Sci (Lond); 2007 Jun; 112(7):375-84. PubMed ID: 17324119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin II induces matrix metalloproteinase-9 expression via a nuclear factor-kappaB-dependent pathway in vascular smooth muscle cells.
    Guo RW; Yang LX; Wang H; Liu B; Wang L
    Regul Pept; 2008 Apr; 147(1-3):37-44. PubMed ID: 18252266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A specific binding site for angiotensin II(3-8), angiotensin IV, in rabbit cardiac fibroblasts.
    Wang L; Eberhard M; Kohler E; Erne P
    J Recept Signal Transduct Res; 1995; 15(1-4):517-27. PubMed ID: 8903961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of disease: local renin-angiotensin-aldosterone systems and the pathogenesis and treatment of cardiovascular disease.
    Re RN
    Nat Clin Pract Cardiovasc Med; 2004 Nov; 1(1):42-7. PubMed ID: 16265259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin II type 1 receptor-dependent nuclear factor-kappaB activation-mediated proinflammatory actions in a rat model of obstructive acute pancreatitis.
    Chan YC; Leung PS
    J Pharmacol Exp Ther; 2007 Oct; 323(1):10-8. PubMed ID: 17616560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin II: a key factor in the inflammatory and fibrotic response in kidney diseases.
    Ruiz-Ortega M; Rupérez M; Esteban V; Rodríguez-Vita J; Sánchez-López E; Carvajal G; Egido J
    Nephrol Dial Transplant; 2006 Jan; 21(1):16-20. PubMed ID: 16280370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal and vascular hypertension-induced inflammation: role of angiotensin II.
    Ruiz-Ortega M; Esteban V; Rupérez M; Sánchez-López E; Rodríguez-Vita J; Carvajal G; Egido J
    Curr Opin Nephrol Hypertens; 2006 Mar; 15(2):159-66. PubMed ID: 16481883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The angiotensin IV system: functional implications.
    Wright JW; Krebs LT; Stobb JW; Harding JW
    Front Neuroendocrinol; 1995 Jan; 16(1):23-52. PubMed ID: 7768321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Tissue consequence of renin-angiotensin system activation].
    Michel JB
    Bull Acad Natl Med; 2004; 188(4):611-9; discussion 620. PubMed ID: 15587680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The intracellular renin-angiotensin system: implications in cardiovascular remodeling.
    Kumar R; Singh VP; Baker KM
    Curr Opin Nephrol Hypertens; 2008 Mar; 17(2):168-73. PubMed ID: 18277150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Vascular endothelial cells and renin-angiotensin system].
    Rakugi H; Nakamura Y; Ohishi M; Okamura A; Yanagitani Y; Higaki J; Ogihara T
    Rinsho Byori; 1998 Nov; 46(11):1135-41. PubMed ID: 9868299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.